Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)

Hyundai Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	545,923	1,038,982	1,087,244	976,101	1,048,678	486,740
Market Cap Growth	-34.84%	-4.44%	11.39%	-6.92%	115.45%	166.35%
Enterprise Value	563,216	1,031,571	1,069,527	969,321	1,050,097	491,980
Last Close Price	13710.00	24591.94	25816.83	23791.06	27512.82	13238.19
PE Ratio	-	-	-	-	-	434.04
PS Ratio	34.51	109.58	138.47	105.62	83.82	16.18
PB Ratio	12.48	22.95	18.67	15.85	20.04	10.19
P/TBV Ratio	72.14	73.68	43.38	34.98	81.02	17.17
P/FCF Ratio	109.72	-	-	-	-	79.62
P/OCF Ratio	150.69	-	-	-	139.79	53.03
EV/Sales Ratio	35.61	108.80	136.22	104.89	83.93	16.35
EV/EBITDA Ratio	1045.17	-	-	-	-	78.93
EV/EBIT Ratio	9967.64	-	-	-	-	203.31
EV/FCF Ratio	113.20	-	-	-	-	80.47
Debt / Equity Ratio	0.58	0.12	0.11	0.25	0.71	0.28
Debt / EBITDA Ratio	33.74	-	-	-	-	2.16
Debt / FCF Ratio	5.09	-	-	-	-	2.20
Asset Turnover	0.24	0.16	0.11	0.11	0.16	0.51
Inventory Turnover	2.82	1.62	1.63	1.59	1.19	3.23
Quick Ratio	0.32	1.77	2.23	1.73	3.41	1.77
Current Ratio	0.34	2.18	2.67	2.02	4.37	2.29
Return on Equity (ROE)	-21.50%	-28.02%	-26.39%	-35.21%	-16.50%	3.56%
Return on Assets (ROA)	0.07%	-10.20%	-22.24%	-6.66%	-3.51%	2.56%
Return on Capital (ROIC)	0.08%	-10.63%	-23.24%	-6.97%	-3.67%	2.73%
Earnings Yield	-1.92%	-1.40%	-1.45%	-2.05%	-0.79%	0.23%
FCF Yield	0.91%	-0.63%	-1.66%	-0.44%	-1.69%	1.26%
Buyback Yield / Dilution	-0.18%	-1.04%	-6.64%	-2.79%	-3.67%	-2.75%
Total Shareholder Return	-0.18%	-1.04%	-6.64%	-2.79%	-3.67%	-2.75%

Source: S&P Capital IQ. Standard template. Financial Sources.